News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Smith & Nephew plc (LON:SN.) is favoured by institutional owners who hold 88% of the company [Yahoo! Finance]

Read the ruling [The New York Times]

Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Kepler Capital Markets to a "strong-buy" rating.

Smith & Nephew SNATS (NYSE:SNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $36.00 to $34.00. They now have a "hold" rating on the stock.

Smith+Nephew comparative study1 shows PICO? sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Kepler Capital Markets

Form 6-K SMITH & NEPHEW PLC For: Dec 01

Form 6-K SMITH & NEPHEW PLC For: Nov 19

Form 6-K SMITH & NEPHEW PLC For: Nov 18

Form 6-K SMITH & NEPHEW PLC For: Nov 12

Form 6-K SMITH & NEPHEW PLC For: Nov 12

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}